Related Experiment Videos
Estrogen and progesterone effects on transcapillary fluid dynamics.
N S Stachenfeld1, D L Keefe, S F Palter
1The John B. Pierce Laboratory and Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06519, USA. nstach@jbpierce.org
Summary
Estrogen (E(2)) alone did not alter plasma volume (PV) regulation by atrial natriuretic peptide (ANP). However, combined estrogen and progesterone (P(4)) treatment reduced PV loss during ANP infusion by decreasing capillary filtration coefficient (CFC).
Area of Science:
- Endocrinology
- Cardiovascular Physiology
- Reproductive Biology
Background:
- Atrial natriuretic peptide (ANP) plays a crucial role in regulating plasma volume (PV) and fluid dynamics.
- Estrogen (E(2)) and progesterone (P(4)) are key reproductive hormones with known effects on cardiovascular function.
- The specific impact of E(2) and P(4) on ANP-mediated fluid shifts requires further elucidation.
Purpose of the Study:
- To investigate the effects of E(2) and P(4) on the control of PV and transcapillary fluid dynamics by ANP.
- To determine how E(2) administration alone, and in combination with P(4), influences ANP's actions on fluid balance.
Main Methods:
- Reproductive function was suppressed in 12 women using a GnRH analog.
- Participants received either E(2) alone or E(2) with P(4) for 4 days.
- Plasma volume (PV) and forearm capillary filtration coefficient (CFC) were measured during ANP infusion.
Main Results:
- E(2) treatment alone did not significantly alter preinfusion PV or PV loss during ANP infusion compared to GnRH analog alone.
- E(2) treatment alone increased CFC during ANP infusion.
- Combined E(2)-P(4) treatment reduced baseline PV and significantly lowered CFC during ANP infusion.
- E(2)-P(4) treatment attenuated PV loss during ANP infusion.
Conclusions:
- Estrogen (E(2)) alone has minimal impact on ANP's regulation of plasma volume (PV) and transcapillary fluid dynamics.
- The combination of estrogen and progesterone (E(2)-P(4)) significantly alters fluid dynamics by reducing capillary filtration coefficient (CFC).
- E(2)-P(4) treatment attenuates plasma volume loss during atrial natriuretic peptide (ANP) infusion, suggesting a protective role in fluid balance regulation.